Prolactin regulation of Bcl-2 family members: Increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells

Journal of Endocrinology

Volumn 178, Issue 2, 2003, Pages 265-273

  Kochendoerfer, S K ^b   Krishnan, N ^a   Buckley, D J ^a   Buckley, Arthur R ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; MESSENGER RNA; PROLACTIN; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; PROTEIN TYROSINE KINASE; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATTENUATION; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOLYSIS; GENE EXPRESSION; IMMUNOBLOTTING; KINETICS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REGULATOR GENE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THYMOCYTE;

ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; BLOTTING, NORTHERN; CARRIER PROTEINS; CELLS, CULTURED; DEXAMETHASONE; ELECTROPORATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; IMMUNOBLOTTING; JANUS KINASE 2; MICE; NEOPLASM PROTEINS; PROLACTIN; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0042854950     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1780265     Document Type: Article

References (42)

1. Al-Sakkaf KA, Dobson PRM & Brown BL 1996 Activation of phosphatidylinositol 3-kinase by prolactin in Nb2 cells. Biochemical and Biophysical Research Communications 221 779-784.
2. Andreeff M, Jiang S, Zhang X, Konopleva M, Estrov Z, Snell VE, Xie Z, Okcu MF, Sanchez-Williams G, Dong J, Estey EH, Champlin RC, Kornblau SM, Reed JC & Zhao S 1999 Expression of Bcl-2 related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid. Leukemia 13 1881-1892.
3. Ashwell JD, Lu FWM & Vacchio MS 2000 Glucocorticoids in T cell development and function. Annual Review of Immunology 18 309-345.
4. Borg KE, Zhang M, Hege D, Stephen RL, Buckley DJ, Magnuson NS & Buckley AR 1999 Prolactin regulation of pim-1 expression: positive and negative promoter elements. Endocrinology 140 5659-5668.
5. Bouchard B, Ormandy CJ, DiSanto JP & Kelly PA 1999 Immune system development and function in prolactin receptor-deficient mice. Journal of Immunology 163 576-582.
6. Buckley AR, Rao Y-P, Buckley DJ & Gout PW 1994 Prolactin-induced phosphorylation and nuclear translocation of MAP kinase in Nb2 lymphoma cells. Biochemical and Biophysical Research Communications 204 1158-1164.
7. Buckley AR, Buckley DJ, Leff MA, Hoover DS & Magnuson NS 1995 Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells. Endocrinology 136 5252-5259.
8. Campbell GS, Argetsinger IS, Ihle JN, Kelly PA, Rillema JA & Carter-Su C 1994 Activation of Jak2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. PNAS 91 5232-5236.
9. Clevenger CV & Medaglia MV 1994 The protein tyrosine kinase P59 fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T lymphocytes. Molecular Endocrinology 8 674-681.
10. Desagher S & Martinou JC 2000 Mitochondria as the central control point of apoptosis. Trends in Cell Biology 10 369-377.
11. Dugan A, Thellin O, Buckley DJ, Buckley AR, Ogle CK & Horseman ND 2002 Effects of prolactin deficiency on myelopoiesis and splenic T lymphocyte proliferation in thermally injured mice. Endocrinology 143 4147-4151.
12. L. Journal of Biological Chemistry 274 2225-2233.
13. Fletcher-Chiappini SE, Comptom MM, LaVoie HA, Day EB & Witorsch RJ 1993 Glucocorticoid-prolactin interactions in Nb2 lymphoma cells: antiproliferative versus anticytolytic effects. Proceedings of the Society for Experimental Biology and Medicine 202 345-352.
14. Gagnerault MC, Tourine P, Savino W, Kelly PA & Dardenne M 1993 Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. Journal of Immunology 150 5673-5681.
15. Gout PW, Beer CT & Noble RL 1980 Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Research 40 2433-2436.
16. Hooghe-Peters EL, Dogusan Z & Hooghe R 2001 In vitro effects of prolactin on the lympho-hemopoietic system. In Prolactin, pp 317-339. Ed. ND Horseman. Boston/Dordrecht/London: Kluwer Academic Publishers.
17. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E & Dorshkind K 1997 Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO Journal 16 6926-6935.
18. Huang Z 2000 Bcl-2 family proteins as targets for anticancer drug design. Oncogene 27 6627-6631.
19. Kluck RM, Bossy-Wetzel E, Green DR & Newmeyer DD 1997 The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275 1132-1136.
20. Krishnan N, Buckley DJ, Zhang M, Reed JC & Buckley AR 2001 Prolactin-stimulated X-linked inhibitor of apoptosis protein expression during S phase cell cycle progression in rat Nb2 lymphoma cells. Endocrine 15 177-186.
21. Krishnan N, Thellin O, Buckley DJ, Horseman ND & Buckley AR 2003 Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology 144 2102-2110.
22. Krumenacker JS, Buckley DJ, Leff MA, McCormack JT, De Jong G, Gout PW, Reed JC, Miyashita T, Magnuson NS & Buckley AR 1998 Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression. Endocrine 9 163-170.
23. Krumenacker JS, Narang VS, Buckley DJ & Buckley AR 2001 Prolactin signaling to pim-1 expression: a role for phosphatidylinositol 3-kinase. Journal of Neuroimmunology 113 249-259.
24. Leff MA, Buckley DJ, Krumenacker JS, Reed JC, Miyashita T & Buckley AR 1996 Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology 137 5456-5462.
25. Leverrier Y, Thomas J, Mathieu AL, Low W, Blanquier B & Marvel J 1999 Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells. Cell Death and Differentiation 6 290-296.
26. Lilly M & Kraft A 1997 Enforced expression of the Mr 33 000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells. Cancer Research 57 5348-5355.
27. Lord JD, McIntosh BC, Greenberg PD & Nelson BH 2000 The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. Journal of Immunology 164 2533-2541.
28. Martinou JC & Green DR 2001 Breaking the mitochondrial barrier. Nature Reviews. Molecular Cell Biology 2 63-67.
29. Montgomery DW 2001 Prolactin production by immune cells. Lupus 10 665-675.
30. Moriggl R, Topham DJ, Teglund S, Sexl V, McKay C, Wang D, Hoffmeyer A, van Deursen J, Sangster MY, Bunting KD, Grosveld GC & Ihle JN 1999 Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10 249-259.
31. Pastorino JG, Chen ST, Tafani M, Snyder JW & Farber JL 1998 The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. Journal of Biological Chemistry 273 7770-7775.
32. Rosa-Santos SC, Dumon S, Mayeux P, Gisselbrecht S & Gouilleux F 2000 Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line. Oncogene 19 1164-1172.
33. Rui H, Kirken RA & Farrar WL 1994 Activation of receptor-associated tyrosine kinase Jak2 by prolactin. Journal of Biological Chemistry 269 5364-5368.
34. Russell DH, Kibler R, Matrisian L, Larson DF, Poulos B & Magun BE 1985 Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. Journal of Immunology 134 3027-3031.
35. Schwertfeger KL, Hunter S, Heasley LE, Lavresse V, Leon RP, DeGregori J & Anderson SM 2000 Prolactin stimulates activation of c-jun N-terminal kinase (JNK). Molecular Endocrinology 14 1592-1602.
36. -/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98 181-191.
37. Witorsch RJ, Day EB, LaVoie HA, Hashemi N & Taylor JK 1993 Comparison of glucocorticoid-induced effects in prolactin-dependent and autonomous rat Nb2 lymphoma cells. Proceedings of the Society for Experimental Biology and Medicine 203 454-460.
38. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP & Wang X 1997 Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275 1129-1132.
39. Zellweger R, Zhu XH, Wichmann MW, Ayala A, De Maso CM & Chaudry IH 1996a Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. Journal of Immunology 157 5748-5754.
40. Zellweger R, Zhu XH, Wichmann MW, Ayala A, De Maso CM & Chaudry IH 1996b Prolactin: a novel and safe immunomodulating hormone for the treatment of immunodepression following severe hemorrhage. Journal of Surgical Research 63 53-58.
41. Zhaung H, Patel SV, He T-C, Sonsteby SK, Niu Z & Wojchowski DM 1994 Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2. Journal of Biological Chemistry 269 21411-21414.
42. Zimmermann KC & Green DR 2001 How cells die: apoptosis pathways. Journal of Allergy and Clinical Immunology 108 (Suppl 4) S99-S103.